Basics X4 Pharmaceuticals Inc Arsanis Inc is a biopharmaceutical company. It is engaged in the discovery, development and commercialization of monoclonal antibodies for the targeted immunotherapy of serious infections. IPO Date: May 13, 2022 Sector: Healthcare Industry: Biotech Market Cap: $4.91M Activated in VL: True Average Daily Range Avg Daily Range: $0.07 | 5.15% Avg Daily Range (30 D): $0.02 | 4.60% Avg Daily Range (90 D): $0.02 | 3.55% Institutional Daily Volume Avg Daily Volume: .65M Avg Daily Volume (30 D): 3.88M Avg Daily Volume (90 D): 1.42M Trade Size Avg Trade Size (Sh.): 215 Avg Trade Size (Sh.) (30 D): 479 Avg Trade Size (Sh.) (90 D): 459 Institutional Trades Total Inst.Trades: 10 Avg Inst. Trade: $.93M Avg Inst. Trade (30 D): $2.54M Avg Inst. Trade (90 D): $2.54M Avg Inst. Trade Volume: .18M Avg Inst. Trades (Per Day): 5 Market Closing Trades Avg Closing Trade: $.53M Avg Closing Trade (30 D): $M Avg Closing Trade (90 D): $M Avg Closing Volume: 142.9K     News Jul 1, 2025 @ 12:00 PM Actelis Networks Announces Private Placement Price... Source: Actelis Networks, Inc. May 14, 2025 @ 12:04 PM US Stock Futures Trade Higher On Wednesday: S&P 50... Source: Rishabh Mishra May 14, 2025 @ 10:49 AM US Stock Futures Trade Lower On Wednesday: S&P 500... Source: Rishabh Mishra Aug 14, 2024 @ 9:45 PM Actelis Networks Reports Q2 2024 Results: 372% Seq... Source: N/A Jul 11, 2024 @ 9:16 AM Why WD-40 Shares Are Trading Higher By Over 12%; H... Source: Avi Kapoor Financials   TTM Q2 2025 Q1 2025 Basic EPS $-3.81 $-.21 $-.22 Diluted EPS $-3.81 $-.21 $-.22 Revenue $ 4.64M $ .94M $ .72M Gross Profit $ -.88M $ .31M $ .25M Net Income / Loss $ -101.98M $ -1.9M $ -1.86M Operating Income / Loss $ -105.89M $ -1.77M $ -1.81M Cost of Revenue $ 5.57M $ .64M $ .47M Net Cash Flow $ -107.97M $ -.73M $ -.84M PE Ratio     Splits Apr 19, 2023:   1:10 Mar 14, 2019:   1:6